Healthintersections.com.au

Grahame Grieve B.Sc. MAACB FACHI Grahame Grieve specializes in healthcare interoperability, balancing clinical, management and business perspectives with a deep technical knowledge and capability. Grahame works with many organizations to provide leadership with regard to product development, clinical safety, integration architecture, and standards implementation and development. Grahame has also conceived, developed and sold interoperability and clinical document solutions and products. In addition, Grahame is involved in a number of open source industry consortiums. Grahame is deeply involved in the healthcare standards development process, principally at HL7. Over an eight year period he has used committee chair positions and editorship of key structural standards to lead convergence between US, international and European standards organizations. For this work he was awarded the HISA Don Watson Award for Effectiveness in Health Informatics in 2009. Grahame’s current focus is to define a new more practical interoperability solution called FHIR. Grahame lives in Melbourne, Australia, with his wife and two daughters. Grahame sometimes plays the piano and didgeridoo, and very occasionally gets to go kayak fishing. Grahame is a citizen of both Australia and the United Kingdom, and can be contacted Skills & Expertise OUTCOMES
Standards Development, Implementation & Adoption Enterprise, Architecture & Governance Open Source & Tool Development, Interoperability Toolkits STANDARDS
Internationally recognised expert, committee chair, and editor of several key standards – covering v2, v3, and CDA + implemented many. Principal architect for FHIR (http://hl7.org/fhir) Architect & Lead for open source webservices toolkit DEVELOPMENT TOOLS
Deep experience for many years in all contexts of use Implemented Eclipse Instance Editor for OHT Industry Roles  Project Lead & Lead Committer, Eclipse  Project Lead– Webservices Toolkit 1999+ &Committer (open source Delphi)  Member: eHealth Industry Clinical Safety and Security Committee  Expert Speaker: Clinical Safety, HL7 subjects, Delphi Programming MELBOURNE, AUSTRALIA, 02/2011 TO PRESENT
Integration and Interoperability consulting, including: Clinical Document Expert for Australian National Program Implementation and Adoption for many vendors MELBOURNE, AUSTRALIA, 02/1997 TO 12/2010
Technical Leadership, Consulting, Standards Development, Industry Liason, Interoperability Projects, Business Direction Administration and management responsibilities for all Kestral development (hiring+firing, programming culture & policies) + ISO 9001 Responsible for the development, sales, implementation and ongoing support of clinical portals, HL7 interface engine , clinical documents, and other communications solutions (ongoing to 2010) MELBOURNE, AUSTRALIA, 06/1990 TO 02/1997
Clinical Researcher Ph.D. Thesis: “Modifications of LDL and Lp(a) in Diabetes Mellitus” Laboratory Scientist (Diagnostics & Research) QUALIFICATIONS
Auckland University, NZ. Major: Biochemistry & Cell Biology Publications / Prizes  MAACB examiner’s prize (1992)  “Gemfibrozil treatment increases low-density lipoprotein particle size in Type 2 diabetes mellitus but does not alter in vitro oxidizability”,  “A Cross-Sectional Study of the Effects of Type 2 Diabetes and Other Cardiovascular Risk Factors on Structure and Function of Nonstenotic Arteries of the Lower Limb  “Factors influencing Lp[a]- particle size as determined by gradient gel electrophoresis “Fast Healthcare Interoperability Resources”

Source: http://www.healthintersections.com.au/resumes/ggresume.pdf

Producción de pasto estrella para el ganado ovino en base al mejoramiento organo-mineral de un suelofersialítico

Aplicación de técnicas acupunturales como complemento de la antibiótico terapia en la neumonía porcina Arnielis Díaz Fernández, Erlán Pereira Pargas, Florángel Vidal Fernández, Roberto Vázquez Montes de Oca y Julio Mompié Carmona Facultad de Ciencias Agropecuarias. Universidad de Camagüey Para el tratamiento de la neumonía en cerdos, se estudió la efectividad de dos técnicas acu

Oral oncology referral form

 Specialty Pharmacy Provider:________________ Date: ___________ Date Medication Required:____________ Phone: (855) 535-1815 Ship to:  Physician  Patient’s Home  Other __________ Fax: (855) 815-9894 Prior Authorization Form Juxtapid Patient Name: ___________________________________________________ Physician Name: _______________________________________________ Ad

Copyright © 2010 Health Drug Pdf